CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer...
Cincinnati, Ohio, United States and 18 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Cincinnati, Ohio, United States and 226 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Cincinnati, Ohio, United States and 61 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Cincinnati, Ohio, United States and 50 other locations
how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...
Phase 3
Montgomery, Ohio, United States and 118 other locations
This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal (still having periods) women with ER+/HER2- breast...
Phase 2
Edgewood, Kentucky, United States and 7 other locations
The purpose of this study is to determine if enzalutamide given in combination with exemestane is safe and effective in patients with advanced breast...
Phase 2
Cincinnati, Ohio, United States of America and 128 other locations
Some human epidermal growth factor receptor 2 (HER-2) breast cancer patients do not respond or become resistant to current treatmen...
Phase 2
Cincinnati, Ohio, United States and 98 other locations
with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determine...
Phase 2
Dayton, Ohio, United States and 42 other locations
versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane....
Phase 3
Cincinnati, Ohio, United States and 163 other locations
Clinical trials
Research sites
Resources
Legal